Pre-Market Most Active for Jan 10, 2020 : DERM, ACRS, PTLA ... Jan 10, 2020 · Aclaris Therapeutics, Inc. ( ACRS) is +0.52 at $2.38, with 957,330 shares traded. As reported in the last short interest update the days to cover for ACRS is 10.706505; this calculation is based on the average trading volume of the stock. Portola Pharmaceuticals, Inc. ( PTLA) is -9.8899 at $14.85, with 772,173 shares traded. As reported in the ACRS - Aclaris Therapeutics Summary, Stock ... - Benzinga

Aclaris Therapeutics, Inc. Common Stock (ACRS) Stock ... Aclaris Therapeutics, Inc. Common Stock (ACRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ACRS Stock Quote - Aclaris Therapeutics, Inc. Stock Price ... Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Therapeutics and Contract Research segments. Aclaris Therapeutics, Inc. (ACRS) Stock Analysis & News ... Get breaking news and analysis on Aclaris Therapeutics, Inc. (ACRS) stock, price quote and chart, trading and investing tools.

ACRS | Complete Aclaris Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued. Amarin Corporation plc (AMRN) Stock Price, Quote, History ... Find the latest Amarin Corporation plc (AMRN) stock quote, history, news and other vital information to help you with your stock trading and investing. ACRS: Aclaris Therapeutics, Inc. - Zacks Investment Research

ACRS: Aclaris Therapeutics, Inc. - Zacks Investment Research

ACRS | Aclaris Therapeutics Inc. Advanced Charts | MarketWatch Aclaris Therapeutics Inc. advanced stock charts by MarketWatch. View ACRS historial stock data and compare to other stocks and exchanges. Pre-Market Most Active for Jan 10, 2020 : DERM, ACRS, PTLA ...

Mar 15, 2019 · Aclaris Therapeutics, Inc. ( ACRS) is reporting for the quarter ending December 31, 2018.The drug company's consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.94. This value represents a 17.50% decrease compared to the same quarter last year.

Oct 25, 2019 · Aclaris Therapeutics, Inc. Common Stock (ACRS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

Find real-time PDCE - PDC Energy Inc stock quotes, company profile, news and forecasts from CNN Business. Find real-time PDCE - PDC Energy Inc stock quotes, company profile, news and forecasts

Oct 25, 2019 · The penny stock had a heavy gap down on August 18 th and has not been able to recover until the 24 th. The stock price rose 42% while having its largest trading volume in 52-weeks. Actinium’s stock is looking for continuation during October 25 th ’s trading session and is already gapping up 6% in premarket hours.

Pre-Market Most Active for Jan 10, 2020 : DERM, ACRS, PTLA ...